NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
$11.8 -1.46 (-11.0106%)
Analysed NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) News Sources
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
24-07-2026
yahoo.com
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
29-07-2026
yahoo.com
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
05-08-2026
yahoo.com
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates
05-08-2026
yahoo.com
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
05-08-2026
marketbeat.com
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
26-08-2026
yahoo.com
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
02-09-2026
yahoo.com
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-09-2026
yahoo.com
Novartis Trial Failure Sparks Biopharma Options Frenzy
08-09-2026
yahoo.com
How Novartis' Double-Stacked Failures Reverberated Through Biopharma
08-09-2026
yahoo.com
What is the current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is $11.8.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is $-1.46.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is -11.0106%.
What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is 52 out of 100.
What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is .
SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.